ArticleDepression and anxiety2026
Cross-Disease Classification of Depression, Bipolar Disorder, and Schizophrenia Using Multiscale Spatiotemporal Network Fusion Features From fNIRS.
Article in Depression and anxiety, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Major depressive disorder (MDD), bipolar disorder (BD), and schizophrenia (SCZ) are highly prevalent and disabling psychiatric conditions with increasing incidence, significantly affecting individuals' daily functioning, social relationships, and overall quality of life. Current diagnostic practices largely rely on clinical interviews and symptom-based rating scales, which are inherently subjective and time-consuming-posing major obstacles to large-scale screening. Methods: To address this, we propose a novel multiscale spatiotemporal network fusion (MSNF) feature extraction method based on functional near-infrared spectroscopy (fNIRS) combined with the verbal fluency test (VFT). This method is designed to enable objective, efficient, and automated differentiation among multiple psychiatric disorders (MDD, BD, and SCZ), as well as between patient groups and healthy controls (HCs). Leveraging the practical advantages of fNIRS, including its portability, motion tolerance, and balanced spatiotemporal resolution, the proposed MSNF fuses temporal dynamics with graph-theoretical topology, capturing both local hemodynamic dynamics and hierarchy connectivity patterns. Results: In this study, a total of 414 participants were recruited, including individuals diagnosed with MDD, BD, SCZ, and HCs. Classification experiments using machine learning (ML) models demonstrate the proposed method's robustness and superior diagnostic performance in binary and multiclass settings, outperforming traditional unidimensional feature approaches. Additionally, group-level functional connectivity (FC) analyses reveal distinct neurobiological signatures among psychiatric groups. Conclusions: These findings underscore the translational potential of MSNF-enhanced fNIRS as a scalable neuroimaging-based biomarker tool for early psychiatric screening and differential diagnosis.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.